| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04471974 | ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting | 2026-07-23 |
| NCT03682289 | Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients… | Clear Cell Renal Cell Carcinoma | Active, Not Recruiting | 2026-04-23 |
| Phase 1/2 | ||||
| NCT05888532 | 64Cu-GRIP B in Patients With Advanced Malignancies | Prostate Cancer | Recruiting | 2026-03-17 |
| NCT05011188 | FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting | 2026-09-17 |
| Phase 1 | ||||
| NCT06942104 | Imaging of Solid Tumors Using 18F-TRX | Solid Tumor | Recruiting | 2026-07-23 |
Prostate Cancer (5) · Kidney Cancer (3) · Bladder Cancer (1) · Endometrial Cancer (1) · Glioma (1) · Pancreatic Cancer (1)